Global Artificial Intelligence (AI) in Drug Discovery Market to 2032
Overview
The Global Artificial Intelligence (AI) in Drug Discovery Market is expected to reach a 68.77 USD Billion by 2032 and is projected to grow at a CAGR of 85.20% from 2025 to 2032.
Global Artificial Intelligence (AI) in Drug Discovery Market 2018-2032 USD Billion
Global Artificial Intelligence (AI) in Drug Discovery Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 2.45 USD Billion
- Projected Market Size (2032): 68.77 USD Billion
- CAGR (2025-2032): 85.20%
Key Findings of Global Artificial Intelligence (AI) in Drug Discovery Market
- The Global Artificial Intelligence (AI) in Drug Discovery Market was valued at 2.45 USD Billion in 2024.
- The Global Artificial Intelligence (AI) in Drug Discovery Market is likely to grow at a CAGR of 85.20% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Small Molecule in Drug Type Segment accounted for the largest share of the market with a revenue of 1.91 USD Billion
- The fastest growing segment Novel Drug Candidates in Application Segment grew Fastest with a CAGR of 98.10% during the forecast period from 2024 to 2032.
Global Artificial Intelligence (AI) in Drug Discovery Market Scope
- Others
- Finding New Disease-Associated Targets and Pathways
- Understanding Disease Mechanisms
- Formation & Qualification of Hypotheses
- Finding Drug Targets of an Old Drug
- De Novo Drug Design
- Aggregating and Synthesizing Information
- Drug Monitoring
- Drug Optimisation and Re-purposing Pre-clinical testing and approval
- Novel Drug Candidates
- Others
- Metabolic Diseases
- Cardiovascular Diseases
- Neurodegenerative Diseases
- Immuno-Oncology
- Services
- Software
- Others
- Natural Language Processing (NLP)
- Deep Learning
- Machine Learning (ML)
- Large Molecule
- Small Molecule
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
Global Artificial Intelligence (AI) in Drug Discovery Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2020 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 2.45 USD Billion |
| Market Value in 2032 | 68.77 USD Billion |
| CAGR (2025-2032) | 85.20% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Application,Indication,Offering,Technology,Drug Type,End User |
Regional Insights:
-
Leading Market (2024-2032): Global, leading in terms of revenue 2.45 USD Billion in 2024
- Key Country: U.S., leading in terms of revenue with value of 1,151.46 USD Million in 2024.
Segments and Scope
-
Global Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Application
- Novel Drug Candidates is the largest segment in Global Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 751.81 USD Billion in the year 2024.
- Novel Drug Candidates is the Fastest growing segment in Global Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 98.10 % in forecast period 2025-2032.
-
Global Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Indication
- Immuno-Oncology is the largest segment in Global Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 990.54 USD Billion in the year 2024.
- Immuno-Oncology is the Fastest growing segment in Global Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 88.53 % in forecast period 2025-2032.
-
Global Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Offering
- Software is the largest segment in Global Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 1.56 USD Billion in the year 2024.
- Services is the Fastest growing segment in Global Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 82.02 % in forecast period 2025-2032.
-
Global Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Technology
- Machine Learning (ML) is the largest segment in Global Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 1.24 USD Billion in the year 2024.
- Machine Learning (ML) is the Fastest growing segment in Global Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 88.05 % in forecast period 2025-2032.
-
Global Artificial Intelligence (AI) in Drug Discovery Market to 2032, By Drug Type
- Small Molecule is the largest segment in Global Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 1.91 USD Billion in the year 2024.
- Small Molecule is the Fastest growing segment in Global Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 85.92 % in forecast period 2025-2032.
-
Global Artificial Intelligence (AI) in Drug Discovery Market to 2032, By End User
- Contract Research Organizations is the largest segment in Global Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a revenue of 1.14 USD Billion in the year 2024.
- Contract Research Organizations is the Fastest growing segment in Global Artificial Intelligence (AI) in Drug Discovery Market to 2032 with a Growth rate of 90.39 % in forecast period 2025-2032.
Global Artificial Intelligence (AI) in Drug Discovery Market Company Share Analysis
| Company Name |
|
||
| Microsoft | |||
| NVIDIA Corporation | |||
| IBM Corporation | |||
| Schrödinger, Inc. | |||
| BPGbio, Inc. | |||
Global Artificial Intelligence (AI) in Drug Discovery Market Geographical Sales Distribution, 2018-2032 USD Billion
Global Artificial Intelligence (AI) in Drug Discovery Market Company Profiling
Industry Related Reports
Frequently Asked Questions
Coming Soon....
Global Artificial Intelligence (AI) in Drug Discovery Market Scope
- Others
- Finding New Disease-Associated Targets and Pathways
- Understanding Disease Mechanisms
- Formation & Qualification of Hypotheses
- Finding Drug Targets of an Old Drug
- De Novo Drug Design
- Aggregating and Synthesizing Information
- Drug Monitoring
- Drug Optimisation and Re-purposing Pre-clinical testing and approval
- Novel Drug Candidates
- Others
- Metabolic Diseases
- Cardiovascular Diseases
- Neurodegenerative Diseases
- Immuno-Oncology
- Services
- Software
- Others
- Natural Language Processing (NLP)
- Deep Learning
- Machine Learning (ML)
- Large Molecule
- Small Molecule
- Others
- Research Centres and Academic Institutes
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations
Frequently Asked Questions
Global Artificial Intelligence (AI) in Drug Discovery Market Company Profiling
Frequently Asked Questions
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.